First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin (SQUIRE)
This study is ongoing, but not recruiting participants.
Laboratory Corporation of America
University of Colorado, Denver
Thermo Fisher Scientific
ICON Clinical Research
Pacific Biomarker Inc.
Information provided by (Responsible Party):
First received: September 18, 2009
Last updated: July 3, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||December 2014|
|Primary Completion Date:||June 2013 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Received:||September 7, 2010|